Yannick D Benoit

7PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2025
Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors.

Veronika Yevdokimova, Yannick D Benoit

|Feb 13, 2024
The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.

Christopher J Bergin, Aïcha Zouggar, Amanda Mendes da Silva

|Oct 28, 2023
Colorectal Cancer Is Borrowing Blueprints from Intestinal Ontogenesis.

Jacob L Billingsley, Veronika Yevdokimova, Kristina Ayoub

|Aug 26, 2023
Where to Draw the LINE-Are Retrotransposable Elements Here to Stay?

Christopher J Bergin, Amanda Mendes da Silva, Yannick D Benoit

|Nov 14, 2021
Emerging role of G9a in cancer stemness and promises as a therapeutic target.

Joshua R Haebe, Christopher J Bergin, Tamara Sandouka

|Dec 16, 2020
G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.

Christopher J Bergin, Aïcha Zouggar, Joshua R Haebe

Pageof 2